Brief: Crinetics Pharmaceuticals Appoints Isabel Kalofonos As Chief Commercial Officer
16/12/2024 13:37
Dec 16 (Reuters) - Crinetics Pharmaceuticals Inc
CRNX.O :
* CRINETICS PHARMACEUTICALS APPOINTS ISABEL KALOFONOS
AS CHIEF
COMMERCIAL OFFICER
Source text: ID:nGNX4KhMdx
Further company coverage: CRNX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crinetics Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Crinetics Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Crinetics Q2 revenue jumps on PALSONIFY launch, withdraws guidance
Brief: Crinetics Pharmaceuticals Q2 Net Income USD -120.855 Million